Literature DB >> 8334491

Epidemiology of travel.

D Reid1, J H Cossar.   

Abstract

The unprecedented scale and speed of contemporary international travel means that ever increasing numbers of travellers are exposed to unfamiliar infections and other hazards. Since 1973, surveillance has been conducted at the Communicable Diseases (Scotland) Unit on illnesses affecting returning travellers. This has helped define the perspective of illness associated with travel, to evaluate the effectiveness of pre-travel health advice and to develop a computerised data base designed to give advice on the prevention of travellers' illnesses. These and other epidemiological studies suggest that: (a) younger travellers experience more illness (b) the greater the climatic and cultural contrast between the traveller's country of origin and the destination country, the higher the risk (c) by far the commonest afflictions the traveller is likely to experience are diarrhoea and vomiting (d) the cost of travel-related illness in the UK is in excess of pounds 11 million.

Entities:  

Mesh:

Year:  1993        PMID: 8334491     DOI: 10.1093/oxfordjournals.bmb.a072609

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  3 in total

1.  Risk factors for psychological stress among international business travellers.

Authors:  J Striker; R S Luippold; L Nagy; B Liese; C Bigelow; K A Mundt
Journal:  Occup Environ Med       Date:  1999-04       Impact factor: 4.402

2.  Insights into needs of business travelers to China from calls to a medical assistance provider.

Authors:  Linda Sanftenberg; Michaela Kramer; Stefan Esser; Jörg Schelling
Journal:  Heliyon       Date:  2019-02-15

3.  Effectiveness and economic analysis of the whole cell/recombinant B subunit (WC/rbs) inactivated oral cholera vaccine in the prevention of traveller's diarrhoea.

Authors:  Rosa López-Gigosos; Pedro Garcia-Fortea; Maria J Calvo; Emilia Reina; Rosa Diez-Diaz; Elena Plaza
Journal:  BMC Infect Dis       Date:  2009-05-16       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.